Dyne Therapeutics Inc

Stock Chart, Company Information, and Scan Results

$14.68(as of Oct 9, 3:59 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Dyne Therapeutics Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$14.68
Ticker SymbolDYN
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees206
CountyUSA
Market Cap$2,071.4M

Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. It is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; facioscapulohumeral dystrophy; and Pompe disease, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. The company was incorporated in 2017 and is headquartered in Waltham, Massachusetts.

Dyne Therapeutics Inc In Our Stock Scanner

As of Oct 10, 2025
As of ---
As of ---
example chart graphic
Scan Name: Golden CrossScan Type: Stock Indicator Scans
As of ---
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.